#22 - Tom Dayspring, M.D., FACP, FNLA – Part III of V: HDL, reverse cholesterol transport, CETP inhibitors, and apolipoproteins
The Peter Attia Drive
00:00
Mendelian Randomization
In two thousand, i want to say 11 ish, didn't a mendelian randomization look at this and conclude? Now this was long after these drugs were in the pipe line. Didn't the m r suggest that those people were not better off? I can't wait til we're gon to talk about yanksus. So let's inhibit c e t p, the ls get to keep all their collestra h l clussr goes throe the roof. That's good epidemi logically right? And set o on first principles. It doesn't even make sense in light of what you just told us. No, but they didn't know that then neither.
Transcript
Play full episode
